A plea to Pharmac

On the watch: from left, Garry Dyet, Tim Gunn, Damian Wiseman and Hamish Crocket.

Waipā District Council chief executive Garry Dyet and three other high-profile type one diabetics are calling on Pharmac to increase its funding for them and the country’s 28,000 other sufferers.

They say the investment would reduce health system costs.

The four are part of Nightscout New Zealand, a non-profit advocacy group promoting access to and use of modern technologies for managing type one diabetes.

Type one diabetes is a lifelong auto immune condition where people must maintain a round-the-clock eye on their sugar levels.

About a tenth of the 278,000 people diagnosed with diabetes in New Zealand – type two is a blood glucose disorder usually associated with lifestyle choices – have the type one variant which has no cure.

Insulin – the sugar-regulating hormone produced by the pancreas – is needed by type one diabetics to survive. Just how much insulin they need is a decision they make many times a day.

Dyet, Waikato University social scientist Hamish Crocket, MetOcean scientific systems engineer Tim Gunn and Paralympics New Zealand Waikato cycling hub coach Damian Wiseman say because of the watches they wear and the cellphone app they use, they do not have to do up to eight finger-prick tests each day to assess their blood sugar levels – or make more than 250 life-saving decisions.

The data is there on their wrists and in their phones.

The data is there on their wrists and in their phones. They pay a monthly fee of just under $400 for it and no longer need to constantly interact with primary and secondary care health professionals to access their own status.

A tiny and discreet transmitter on their bodies sends blood glucose data to their watches and phones every few minutes, making it easier for them to make more informed decisions about diabetes management. Data can also be provided to family members – vital when children have type one diabetes – and to their GPs and diabetes healthcare professionals.

#We are not waiting

Having the data readily available enables them to regulate their exercise and medication and decide whether that extra bit of food or drink is going to increase their blood glucose levels.

Dyet started on the trial in 2018 “and never slept so well in my life.”

“The biggest change is that at last you get a sense of being in total control of a condition which would normally dominate your life due to the need for dozens of decisions each day.

“The artificial pancreas makes most of those decisions for you with a programmed response to the data it receives every five minutes.

“Life is much better with a functioning pancreas … even if it is an artificial one,” he says.

“Making continuous blood glucose sensors and ultrafast insulins available would open the door for others to take advantage of this life changing technology, reduce complications and hospitalisations, and significantly improve quality of life for patients and care givers.”

Read more

 

More Recent News

Pirongia gives $17,000

The Pirongia Community Board allocated $17,000 in discretionary funds last week. The board had almost $29,000 in its uncommitted funds to allocate, and 16 applicants sought a total of $32,413. Plunket was allocated the biggest…

Fluoride rates will be ‘safe’

The Prime Minister’s chief science advisor has told Waipā District Council the amount of fluoride going into Cambridge’s water supply is a safe level. Professor Dame Juliet Gerrard was responding to a call from the…

Why you should elect me…

Forty people have paid their deposits and put their names forward for seats on the Waipā council or community boards. So why should we vote for them? Here are the reasons why in their own…

The Age of Reason: Follow the leader ….

This is indeed a tumultuous month with the international scene overshadowed by the sad passing of a wonder lady, mother and world leader. The media from around the world is showering us with completely understandable…